• Zum Hauptinhalt springen
  • Zum Footer springen
  • Notfall
  • Medizinische Klinik und Poliklinik I

Herzklappenz...

  • Aortenklappe
    • Aortenklappenstenose
    • Aortenklappeninsuffizienz
    • Interventionelle Therapieverfahren
    • Chirurgische Therapie
  • Mitralklappe
    • Mitraklappeninsuffizienz
    • Interventionelle Therapieverfahren bei Mitralklappeninsuffizienz
    • Chirurgische Therapie
  • Trikuspidalklappe
    • Trikuspidalklappeninsuffizienz
    • Interventionelle Therapieverfahren bei Trikuspidalklappeninsuffizienz
    • Chirurgische Therapie
    • Erfahrungsberichte nach Behandlung der Trikuspidalklappeninsuffizienz
  • Ambulanz
  • Wissenschaft
    • Klinische Studien
    • Publikationen
  • Team
  • Medien
  • Kontakt
  1. Herzklappenzentrum
  2. Wissenschaft
  3. Publikationen

Publikationen

Im Folgenden bieten wir Ihnen eine Überblick über die wichtigsten Publikationen unserer Arbeitsgruppe.

Publikationsübersicht 2022

  1. Stolz L, Weckbach LT, Karam N, et al. Invasive Right Ventricular to Pulmonary Artery Coupling in Patients Undergoing Transcatheter Edge-to-Edge Tricuspid Valve Repair [published online ahead of print, 2022 Dec 12]. JACC Cardiovasc Imaging. 2022;S1936-878X(22)00608-8. doi:10.1016/j.jcmg.2022.10.004
  2. Scotti A, Coisne A, Taramasso M, et al. Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation [published online ahead of print, 2022 Nov 29]. Eur Heart J. 2022;ehac735. doi:10.1093/eurheartj/ehac735
  3. Stolz L, Doldi PM, Weckbach LT, et al. Heterotopic Transcatheter Tricuspid Valve Replacement in a Patient With Carcinoid Heart Disease. JACC Case Rep. 2022;4(23):101679. Published 2022 Nov 16. doi:10.1016/j.jaccas.2022.10.011
  4. Baldus S, Schofer N, Hausleiter J, et al. Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results. Catheter Cardiovasc Interv. 2022;100(7):1291-1299. doi:10.1002/ccd.30450
  5. Escher F, Fink N, Maurus S, et al. Optimization of Preprocedural Full-cycle Computed Tomography in Patients Referred for Transcatheter Tricuspid Valve Repair: Test Bolus Versus Bolus Tracking [published online ahead of print, 2022 Oct 12]. J Thorac Imaging. 2022;10.1097/RTI.0000000000000682. doi:10.1097/RTI.0000000000000682
  6. Stolz L, Doldi PM, Weckbach LT, et al. Right ventricular function in transcatheter mitral and tricuspid valve edge-to-edge repair. Front Cardiovasc Med. 2022;9:993618. Published 2022 Oct 12. doi:10.3389/fcvm.2022.993618
  7. Steffen J, Andreae D, Nabauer M, et al. TAVI for patients with normal-flow low-gradient compared to high-gradient aortic stenosis. Int J Cardiol. 2023;371:299-304. doi:10.1016/j.ijcard.2022.10.143
  8. Steffen J, Stocker A, Scherer C, et al. Emergency TAVI for acute heart failure due to severe aortic stenosis in critically ill patients with or without cardiogenic shock [published online ahead of print, 2022 Oct 10]. Eur Heart J Acute Cardiovasc Care. 2022;zuac131. doi:10.1093/ehjacc/zuac131
  9. Schlotter F, Dietz MF, Stolz L, et al. Atrial Functional Tricuspid Regurgitation: Novel Definition and Impact on Prognosis. Circ Cardiovasc Interv. 2022;15(9):e011958. doi:10.1161/CIRCINTERVENTIONS.122.011958
  10. Lim DS, Smith RL, Gillam LD, et al. Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients [published online ahead of print, 2022 Sep 8]. JACC Cardiovasc Interv. 2022;S1936-8798(22)01704-6. doi:10.1016/j.jcin.2022.09.005
  11. Higuchi S, Orban M, Adamo M, et al. Sex-specific impact of anthropometric parameters on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation. Int J Cardiol. 2023;371:312-318. doi:10.1016/j.ijcard.2022.09.028
  12. Doldi PM, Stolz L, Kalbacher D, et al. Right ventricular dysfunction predicts outcome after transcatheter mitral valve repair for primary mitral valve regurgitation. Eur J Heart Fail. 2022;24(11):2162-2171. doi:10.1002/ejhf.2661
  13. Gmeiner JMD, Linnemann M, Steffen J, et al. Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation. EuroIntervention. 2022;18(10):812-819. doi:10.4244/EIJ-D-22-00311
  14. Doldi P, Stolz L, Orban M, et al. Transcatheter Mitral Valve Repair in Patients With Atrial Functional Mitral Regurgitation. JACC Cardiovasc Imaging. 2022;15(11):1843-1851. doi:10.1016/j.jcmg.2022.05.009
  15. Wild MG, Löw K, Rosch S, et al. Multicenter Experience With the Transcatheter Leaflet Repair System for Symptomatic Tricuspid Regurgitation. JACC Cardiovasc Interv. 2022;15(13):1352-1363. doi:10.1016/j.jcin.2022.05.041
  16. Stolz L, Braun D, Higuchi S, et al. Transcatheter edge-to-edge mitral valve repair in mitral regurgitation: current status and future prospects [published online ahead of print, 2022 Jul 20]. Expert Rev Med Devices. 2022;1-10. doi:10.1080/17434440.2022.2098013
  17. Higuchi S, Orban M, Adamo M, et al. Guideline-directed medical therapy in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation. Eur J Heart Fail. 2022;24(11):2152-2161. doi:10.1002/ejhf.2613
  18. Doldi P, Steffen J, Orban M, et al. Clinical Outcome Following Transcatheter Aortic Valve Implantation in Patients With Chronic Obstructive Pulmonary Disease. JACC Cardiovasc Interv. 2022;15(11):1188-1190. doi:10.1016/j.jcin.2022.03.017
  19. Iliadis C, Kalbacher D, Lurz P, et al. Left atrial volume index and outcome after transcatheter edge-to-edge valve repair for secondary mitral regurgitation. Eur J Heart Fail. 2022;24(7):1282-1292. doi:10.1002/ejhf.2565
  20. Steffen J, Beckmann M, Haum M, et al. Systolic or diastolic CT image acquisition for transcatheter aortic valve replacement - An outcome analysis. J Cardiovasc Comput Tomogr. 2022;16(5):423-430. doi:10.1016/j.jcct.2022.05.003
  21. Wild MG, Weckbach L, Braun D, et al. Mind the Gap: Facilitating Tricuspid Transcatheter Edge-to-Edge Repair Procedures by Standardized Table Tilt. JACC Cardiovasc Interv. 2022;15(9):1004-1006. doi:10.1016/j.jcin.2022.02.046
  22. Hahn RT, Muraru D, Lurz P, Hausleiter J, Maisano F, Praz F. Reply: The time has come to use attitudinally appropriate terminology when describing cardiac anatomy. EuroIntervention. 2022;17(18):1539-1540. doi:10.4244/EIJ-D-21-01077R
  23. Hahn RT, Hausleiter J. Transmitral Gradients Following Transcatheter Edge-to-Edge Repair: Are Mean Gradients Meaningful?. JACC Cardiovasc Interv. 2022;15(9):946-949. doi:10.1016/j.jcin.2022.02.018
  24. Frerker C, Karam N, Hahn RT, et al. New ESC/EACTS guideline recommendations for the treatment of secondary mitral regurgitation: reflections on the evidence. Eur J Heart Fail. 2022;24(5):746-749. doi:10.1002/ejhf.2497
  25. Ben Ali W, Ludwig S, Duncan A, et al. Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1-year results from the CHOICE-MI registry. Eur J Heart Fail. 2022;24(5):887-898. doi:10.1002/ejhf.2492
  26. Doldi PM, Stolz L, Escher F, et al. Transcatheter Aortic Valve Replacement with the Self-Expandable Core Valve Evolut Prosthesis Using the Cusp-Overlap vs. Tricusp-View. J Clin Med. 2022;11(6):1561. Published 2022 Mar 12. doi:10.3390/jcm11061561
  27. Steffen J, Reißig N, Andreae D, et al. TAVI in patients with low-flow low-gradient aortic stenosis-short-term and long-term outcomes. Clin Res Cardiol. 2022;111(12):1325-1335. doi:10.1007/s00392-022-02011-4
  28. Weckbach LT, Orban M, Kitamura M, et al. Tricuspid Valve Morphology and Outcome in Patients Undergoing Transcatheter Tricuspid Valve Edge-to-Edge Repair. JACC Cardiovasc Interv. 2022;15(5):567-569. doi:10.1016/j.jcin.2021.12.028
  29. Webb JG, Chuang AM, Meier D, et al. Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience. JACC Cardiovasc Interv. 2022;15(5):481-491. doi:10.1016/j.jcin.2022.01.280
  30. Stocker TJ, Cohen DJ, Arnold SV, et al. Durability of benefit after transcatheter tricuspid valve intervention: insights from actigraphy. Eur J Heart Fail. 2022;24(7):1293-1301. doi:10.1002/ejhf.2467
  31. Karam N, Hausleiter J. Can Artificial Intelligence Solve Pulmonary Hypertension Paradox in Severe Tricuspid Regurgitation?. JACC Cardiovasc Interv. 2022;15(4):395-396. doi:10.1016/j.jcin.2022.01.277
  32. Brener MI, Lurz P, Hausleiter J, et al. Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair. J Am Coll Cardiol. 2022;79(5):448-461. doi:10.1016/j.jacc.2021.11.031
  33. Ranard LS, Vahl TP, Chung CJ, et al. Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions. Catheter Cardiovasc Interv. 2022;99(4):1268-1276. doi:10.1002/ccd.30048
  34. Wild MG, Kreidel F, Hell MM, et al. Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience. Eur J Heart Fail. 2022;24(5):899-907. doi:10.1002/ejhf.2434
  35. Stolz L, Orban M, Besler C, et al. Cardiohepatic Syndrome Is Associated With Poor Prognosis in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Valve Repair. JACC Cardiovasc Interv. 2022;15(2):179-189. doi:10.1016/j.jcin.2021.10.033

Publikationsleistung Kardiologie LMU 2022

Publikationsjahr 2022

Kumulative Impactfaktoren gewichtet: 755

Anzahl der Originalarbeiten gesamt: 121

Anzahl Arbeiten Erst-/Letztautorenschaft 84

Anzahl Originalarbeiten Erst-/Letzt 59

Durchschnittsimpactfaktor Erst-/Letzt: 8,99

Anzahl Erstautoren 33

Anzahl Letztautoren 19

Anzahl Publikationen mit Med I Affiliation 154

Kumulativer Impactfaktor aller Publikationen 2402

Klinikum der Ludwig-Maximilians-Universität München

Medizinische Klinik und Poliklinik I

Marchioninistr. 15
81377 München
+49 89 4400 72371  +49 89 4400 78870
Mlpioblüu+Oim2vim ful#vfiuy:ziuemi
Kardiologie LMU Klinikum
Anmeldung für Redakteure
Impressum | Datenschutz
  • Newsletter
  • Zugriff Webmail